VolitionRX Ltd Data Insights Webinar Transcript
Hello. I'm Soo Romanoff. I'm here with the Volition team, and we're excited to share some of their developments in early cancer detection screening.
The Volition team's prepared a video presentation, and we'll share that with you shortly. It will be followed up with Q&A with Louise Batchelor, Group Chief Marketing and Communications Officer; Jake Micallef, Chief Scientific Officer; and Dr. Andrew Retter, a leading UK-based hematologist and medical consultant to Volition. (Event Instructions)
Without further ado, let's get started.
(video starts)
Well, good morning and good afternoon. I'm Gael Forterre, the Chief Commercial Officer of Volition. It's a pleasure to welcome you to this webinar today and to introduce you to Dr. Jake Micallef, our Chief Scientific Officer; and Dr. Andrew Retter for their presentations on the breakthrough cancer detection method.
Before the detailed science, a few words. Our mission is to save
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |